Destabilization of AETFC Through C/EBPα-mediated Repression of LYL1 Contributes to T(8;21) Leukemic Cell Differentiation

Overview

Journal Leukemia

Specialties Hematology
Oncology

Date 2019 Feb 14

PMID 30755707

Citations 5

Authors

Meng-Meng Zhang

Na Liu

Yuan-Liang Zhang

Bowen Rong

Xiao-Lin Wang

Chun-Hui Xu

Yin-Yin Xie

Shuhong Shen

Jiang Zhu

Stephen D Nimer

Zhu Chen

Sai-Juan Chen

Robert G Roeder

Fei Lan

Lan Wang

Qiu-Hua Huang

Xiao-Jian Sun

Affiliations

Soon will be listed here.

Citing Articles

A systematic survey of LU domain-containing proteins reveals a novel human gene, LY6A, which encodes the candidate ortholog of mouse Ly-6A/Sca-1 and is aberrantly expressed in pituitary tumors.

Liu D, Xu C, Liu Y, Ouyang W, Lin S, Xu A Front Med. 2023; 17(3):458-475.

PMID: 36928550 DOI: 10.1007/s11684-022-0968-4.

DNA Methylome and Transcriptome Study of Triterpenoid CDDO in TPA-Mediated Skin Carcinogenesis Model.

Kuo H, Wu R, Sarwar M, Zheng M, Wang C, Sargsyan D AAPS J. 2022; 24(6):115.

PMID: 36324037 DOI: 10.1208/s12248-022-00763-5.

LYL1 facilitates AETFC assembly and gene activation by recruiting CARM1 in t(8;21) AML.

Chen Q, Cevher M, Jiang Q, Wang S, Sun X, Roeder R Proc Natl Acad Sci U S A. 2022; 119(42):e2213718119.

PMID: 36215477 PMC: 9586329. DOI: 10.1073/pnas.2213718119.

A direct comparison between AML1-ETO and ETO2-GLIS2 leukemia fusion proteins reveals context-dependent binding and regulation of target genes and opposite functions in cell differentiation.

Zhang Y, Wang X, Xu C, Liu N, Zhang L, Zhang Y Front Cell Dev Biol. 2022; 10:992714.

PMID: 36158200 PMC: 9490184. DOI: 10.3389/fcell.2022.992714.

Selective and competitive functions of the AAR and UPR pathways in stress-induced angiogenesis.

Zhang F, Zeng Q, Xu H, Xu A, Liu D, Li N Cell Discov. 2021; 7(1):98.

PMID: 34697290 PMC: 8547220. DOI: 10.1038/s41421-021-00332-8.

References

Ptasinska A, Assi S, Martinez-Soria N, Imperato M, Piper J, Cauchy P . Identification of a dynamic core transcriptional network in t(8;21) AML that regulates differentiation block and self-renewal. Cell Rep. 2014; 8(6):1974-1988. PMC: 4487811. DOI: 10.1016/j.celrep.2014.08.024. View

Vavouri T, Semple J, Garcia-Verdugo R, Lehner B . Intrinsic protein disorder and interaction promiscuity are widely associated with dosage sensitivity. Cell. 2009; 138(1):198-208. DOI: 10.1016/j.cell.2009.04.029. View

Bots M, Verbrugge I, Martin B, Salmon J, Ghisi M, Baker A . Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors. Blood. 2014; 123(9):1341-52. PMC: 3938147. DOI: 10.1182/blood-2013-03-488114. View

Ptasinska A, Assi S, Mannari D, James S, Williamson D, Dunne J . Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding. Leukemia. 2012; 26(8):1829-41. PMC: 3419980. DOI: 10.1038/leu.2012.49. View

Cabezas-Wallscheid N, Eichwald V, de Graaf J, Lower M, Lehr H, Kreft A . Instruction of haematopoietic lineage choices, evolution of transcriptional landscapes and cancer stem cell hierarchies derived from an AML1-ETO mouse model. EMBO Mol Med. 2013; 5(12):1804-20. PMC: 3914523. DOI: 10.1002/emmm.201302661. View

Sun X, Wang Z, Wang L, Jiang Y, Kost N, Soong T . A stable transcription factor complex nucleated by oligomeric AML1-ETO controls leukaemogenesis. Nature. 2013; 500(7460):93-7. PMC: 3732535. DOI: 10.1038/nature12287. View

Marcotte E, Tsechansky M . Disorder, promiscuity, and toxic partnerships. Cell. 2009; 138(1):16-8. PMC: 2848715. DOI: 10.1016/j.cell.2009.06.024. View

Rosenbauer F, Tenen D . Transcription factors in myeloid development: balancing differentiation with transformation. Nat Rev Immunol. 2007; 7(2):105-17. DOI: 10.1038/nri2024. View

Semple J, Vavouri T, Lehner B . A simple principle concerning the robustness of protein complex activity to changes in gene expression. BMC Syst Biol. 2008; 2:1. PMC: 2242779. DOI: 10.1186/1752-0509-2-1. View

10.

Martinez Soria N, Tussiwand R, Ziegler P, Manz M, Heidenreich O . Transient depletion of RUNX1/RUNX1T1 by RNA interference delays tumour formation in vivo. Leukemia. 2008; 23(1):188-90. DOI: 10.1038/leu.2008.157. View

11.

Westendorf J, Yamamoto C, Lenny N, Downing J, Selsted M, Hiebert S . The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation. Mol Cell Biol. 1998; 18(1):322-33. PMC: 121499. DOI: 10.1128/MCB.18.1.322. View

12.

Chan W, Follows G, Lacaud G, Pimanda J, Landry J, Kinston S . The paralogous hematopoietic regulators Lyl1 and Scl are coregulated by Ets and GATA factors, but Lyl1 cannot rescue the early Scl-/- phenotype. Blood. 2006; 109(5):1908-16. DOI: 10.1182/blood-2006-05-023226. View

13.

Loke J, Chin P, Keane P, Pickin A, Assi S, Ptasinska A . C/EBPα overrides epigenetic reprogramming by oncogenic transcription factors in acute myeloid leukemia. Blood Adv. 2018; 2(3):271-284. PMC: 5812331. DOI: 10.1182/bloodadvances.2017012781. View

14.

Heidenreich O, Krauter J, Riehle H, Hadwiger P, John M, Heil G . AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells. Blood. 2002; 101(8):3157-63. DOI: 10.1182/blood-2002-05-1589. View

15.

Ohlsson E, Schuster M, Hasemann M, Porse B . The multifaceted functions of C/EBPα in normal and malignant haematopoiesis. Leukemia. 2015; 30(4):767-75. DOI: 10.1038/leu.2015.324. View

16.

Pabst T, Mueller B, Harakawa N, Schoch C, Haferlach T, Behre G . AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia. Nat Med. 2001; 7(4):444-51. DOI: 10.1038/86515. View